ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SN. Smith & Nephew Plc

976.60
-2.40 (-0.25%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.40 -0.25% 976.60 975.40 976.20 1,020.00 971.60 1,000.00 3,782,796 16:35:26
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Ortho,prosth,surg Appl,suply 5.55B 263M 0.3011 32.41 8.52B
Smith & Nephew Plc is listed in the Ortho,prosth,surg Appl,suply sector of the London Stock Exchange with ticker SN.. The last closing price for Smith & Nephew was 979p. Over the last year, Smith & Nephew shares have traded in a share price range of 887.00p to 1,316.00p.

Smith & Nephew currently has 873,398,889 shares in issue. The market capitalisation of Smith & Nephew is £8.52 billion. Smith & Nephew has a price to earnings ratio (PE ratio) of 32.41.

Smith & Nephew Share Discussion Threads

Showing 1176 to 1200 of 1325 messages
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older
DateSubjectAuthorDiscuss
12/4/2023
14:20
Look at the operations lost as a result of the strikes - many may never be recovered as the potential candidates may have passed over to the other place - That is of course if you believe that there is "another place"

So why the share price increase today.

pugugly
04/4/2023
11:05
Disappointing pullback.......
chrisdgb
29/3/2023
11:45
xd date tomorrow to collect 23.1c
jurgenklopp
01/3/2023
22:19
Russ Mould in Questor at S Telegraph has a long note with a hold... Time to give the company one last chance.
cerrito
21/2/2023
11:37
P/E 18 on adjusted basis which is not dear vs historical average of 25 and what Stryker trades at.
justiceforthemany
21/2/2023
10:03
It is the perennial uninspiring results that ultimately will lead to it being taken over.
jurgenklopp
21/2/2023
08:42
Nothing exciting no, but equally still nothing to suggest that they're ever going to deliver decent ROE, ROCE etc

Always felt to me that SN achieves a fraction of its potential. Why...I'm not sure

adamb1978
21/2/2023
07:45
Nothing in the results to make me press the buy or sell button.
Good to see q4 results and progress in orthopedics operations and US LIFR. Confused that they are wary on Q1 citing China covid cases given China Covid has been out of the limelight this month and that we are only half way through the quarter and China just 10pc of sales.
Note FCF flat but can understand why they have had a build up in inventory but note we will need to wait till the AR to see if this was finished goods etcet.

cerrito
17/2/2023
21:34
Soames as chair is a good appointment. Worked wonders at Serco.
justiceforthemany
10/2/2023
09:07
Just over a week to the final results, let us hope we get a real feel for the strategy in the coming years, still a strategic asset....
chrisdgb
05/1/2023
12:20
Yes, it's looking a bit perky!
lizafl
05/1/2023
09:38
Having a nice little run at the moment......
chrisdgb
22/12/2022
08:33
It has long been linked to be a takeover candidate, maybe 2023 will finally seal the deal........
chrisdgb
09/12/2022
16:50
Cheap for starters!
ianood
09/12/2022
09:12
If i may so rudely interrupt here, im intrigued to know why a few of you here are convinced that Smith and Nephew will likely be taken over?
cfro
09/12/2022
08:23
Still hoping for the knockout bid here.......
chrisdgb
07/12/2022
18:37
Questor column has consistently recommended this stock , first as a buy, then a hold and no doubt it will be a sell before long after years of underperformance.
southwinds
07/12/2022
15:38
Glad this wasn't sn.
Suet

suetballs
04/11/2022
17:50
Thanks Cerrito that’s interesting. Can the customer afford to pay - I think we’ll see a lot of that. But I suppose if I had a medical problem I would somehow find the money to sort it.
Suet

suetballs
04/11/2022
17:32
As a SN. holder I listened to most of the recording of yesterday's webcast.
Alot of good stuff especially in logistics and optimization of inventory and US improvement but what stopped me pushing the buy button was not so much the supply shortages(especially semi conductors and resins) but rather that in the Q&A the difficulty they were having on passing on cost increases came up 2/3 times.

cerrito
03/11/2022
10:19
Seem to be following the same stocks!From the healthcare sector I've got SN on my watchlist and good to see they are in line. Some of the constraining factors (materials and staff shortages, FX headwinds) could develop into major issues but who knows.
disc0dave45
03/11/2022
09:40
Trading update seems ok.
Never sure what the market will think these days.
Suet

suetballs
07/9/2022
09:50
Green again on a red day............
chrisdgb
06/9/2022
08:48
unless share price were to move up 10% or more then v v unlikely any rns. in any case i think its a passive stake build. any offer is likely going to have to be over 15/16 quid here and its not a level the board will accept at this point. next year i think that that price will be more acceptable. not necessarily because the share price will be much lower at that time (i dont think they go much below 10 maybe to 950 but if they do then 8 is quite prob in that case) but the longer the share price is lower than the more pressure the board will be under to accept a price around 15/16. personally think its still a lot of money to pay inc of all debt so its only the americans that could be interested.
roguetraderuk
06/9/2022
08:12
Will be interesting if this firms up in the coming days, flush a comment out...?>
chrisdgb
Chat Pages: 53  52  51  50  49  48  47  46  45  44  43  42  Older

Your Recent History

Delayed Upgrade Clock